Results 1 to 10 of about 301,728 (217)

Rapid identification of plasmalogen molecular species using targeted multiplexed selected reaction monitoring mass spectrometry [PDF]

open access: goldJournal of Mass Spectrometry and Advances in the Clinical Lab, 2021
Plasmalogens (Pls) levels are reported to be altered in several neurological and metabolic diseases. Identification of sn-1 fatty alcohols and sn-2 fatty acids of different Pls species is necessary to determine the roles and mechanisms of action of Pls ...
Abul Kalam Azad   +7 more
doaj   +3 more sources

Bayesian Classification of Proteomics Biomarkers from Selected Reaction Monitoring Data using an Approximate Bayesian Computation-Markov Chain Monte Carlo Approach [PDF]

open access: goldCancer Informatics, 2018
Selected reaction monitoring (SRM) has become one of the main methods for low-mass-range–targeted proteomics by mass spectrometry (MS). However, in most SRM-MS biomarker validation studies, the sample size is very small, and in particular smaller than ...
Kashyap Nagaraja, Ulisses Braga-Neto
doaj   +4 more sources

Selected reaction monitoring for the quantification of Escherichia coli ribosomal proteins. [PDF]

open access: yesPLoS ONE, 2020
Ribosomes are the sophisticated machinery that is responsible for protein synthesis in a cell. Recently, quantitative mass spectrometry (qMS) have been successfully applied for understanding the dynamics of protein complexes.
Yuishin Kosaka   +6 more
doaj   +2 more sources

Absolute quantification of transcription factors in human erythropoiesis using selected reaction monitoring mass spectrometry [PDF]

open access: yesSTAR Protocols, 2020
Summary: Quantitative changes in transcription factor (TF) abundance regulate dynamic cellular processes, including cell fate decisions. Protein copy number provides information about the relative stoichiometry of TFs that can be used to determine how ...
Mark A. Gillespie   +5 more
doaj   +2 more sources

Plasma preparation to measure FDA‐approved protein markers by selected reaction monitoring [PDF]

open access: yesClinical and Translational Medicine, 2015
BackgroundThe development of commercially available panels for human blood plasma screening via selected reaction monitoring (SRM) offers reliable, cost‐efficient and highly‐standardized discovery and validation of protein biomarkers.
Olga I. Kiseleva   +6 more
doaj   +2 more sources

Selected Reaction Monitoring (SRM) Analysis of Epidermal Growth Factor Receptor (EGFR) in Formalin Fixed Tumor Tissue [PDF]

open access: goldClinical Proteomics, 2012
Background Analysis of key therapeutic targets such as epidermal growth factor receptor (EGFR) in clinical tissue samples is typically done by immunohistochemistry (IHC) and is only subjectively quantitative through a narrow dynamic range.
Hembrough Todd   +13 more
doaj   +2 more sources

Variance component analysis to assess protein quantification in biomarker validation: application to selected reaction monitoring-mass spectrometry [PDF]

open access: yesBMC Bioinformatics, 2018
Background In the field of biomarker validation with mass spectrometry, controlling the technical variability is a critical issue. In selected reaction monitoring (SRM) measurements, this issue provides the opportunity of using variance component ...
Amna Klich   +12 more
doaj   +2 more sources

Quantitative assay of targeted proteome in tomato trichome glandular cells using a large-scale selected reaction monitoring strategy [PDF]

open access: yesPlant Methods, 2019
Background Glandular trichomes found in vascular plants are called natural cell factories because they synthesize and store secondary metabolites in glandular cells.
Ayako Takemori   +6 more
doaj   +2 more sources

Targeted Phosphoinositides Analysis Using High-Performance Ion Chromatography-Coupled Selected Reaction Monitoring Mass Spectrometry. [PDF]

open access: hybridJ Proteome Res, 2021
Cheung HYF   +9 more
europepmc   +3 more sources

Targeted selected reaction monitoring mass spectrometric immunoassay for insulin-like growth factor 1. [PDF]

open access: yesPLoS ONE, 2013
Insulin-like growth factor 1 (IGF1) is an important biomarker of human growth disorders that is routinely analyzed in clinical laboratories. Mass spectrometry-based workflows offer a viable alternative to standard IGF1 immunoassays, which utilize various
Eric E Niederkofler   +10 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy